@Raki Anything that causes the price to go from 28c to 5c and then take 4 years to get back to 12c is a F-up. Not sure why that needs any further elaboration but let me simplify it for you again
- over hyping impending test results = bad
- rushing test results = bad
- submitting contaminated test samples = bad.
- disappointing test results = bad.
If any of this were to happen again - we're all F'd. The equivalent drop in share price applied to todays price is 2.1c. I am seeing some significant over hyping happening on this forum -very similar to 2017. I personally would prefer to see some cooler heads and some surprising test results - rather than over hype and somewhat disappointing test results. For some reason, Anson is a fragile stock and it can't handle even the slightest of disappointment in these tests. I blame the painful, irrational Lithium bubble hypers and poppers for its fragility - I hope they will be replaced with more long term holders soon.
* I am a shareholder (aver 4.7c). I like this company (a lot) I think it has the potential to achieve a Mcap circa 500m to 1b in the not to distance future. I purchased shares primarily based on their Bromine value. I look forward to these lithium results as it will definitely help them get funding....... as long as they don't F-Up again - like they did in 17/18.
i'm done with responding on this topic.
